About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Current Vascular Pharmacology
›
Top Articles
Current Vascular Pharmacology
Pharmacology
3.3
(top 5%)
Impact Factor
3.6
(top 5%)
extended IF
59
(top 7%)
H-Index
879
authors
1.2K
papers
21.5K
citations
3.3K
citing journals
18.5K
citing authors
Most Cited Articles of Current Vascular Pharmacology
Title
Year
Citations
The role of nitric oxide on endothelial function
2012
520
Ginseng compounds: an update on their molecular mechanisms and medical applications
2009
435
Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture
2005
214
Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement
2011
201
Glucocorticoids and vascular reactivity
2004
201
Apoptosis and Acute Brain Ischemia in Ischemic Stroke
2017
197
Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure
2005
163
Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction
2015
153
Role of oxidative stress in development of cardiovascular complications in diabetes mellitus
2006
139
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
2011
138
Inflammation, sleep, obesity and cardiovascular disease
2007
133
Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms
2007
132
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
2017
132
Nucleoside transporter proteins
2009
118
Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies
2005
116
Endothelin-1-induced signaling pathways in vascular smooth muscle cells
2007
111
Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer
2004
111
Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature
2006
110
Angiogenesis-regulating microRNAs and Ischemic Stroke
2015
107
Endothelial dysfunction, obesity and insulin resistance
2014
106
Hypertension and endothelial dysfunction: therapeutic approach
2012
105
Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease
2006
99
Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis
2008
98
Migraine: pathophysiology, pharmacology, treatment and future trends
2003
98
Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system
2006
96
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.